Table 2.
KEGG Pathway Term | N | % | P value |
HSA04810:REGULATION OF ACTIN CYTOSKELETON | 43 | 2.81 | 1.7E-07 |
HSA04510:FOCAL ADHESION | 45 | 2.94 | 3.5E-07 |
HSA04010:MAPK SIGNALING PATHWAY | 41 | 2.68 | 3.9E-05 |
HSA04512:ECM-RECEPTOR INTERACTION | 17 | 1.11 | 0.0029 |
HSA04070:PHOSPHATIDYLINOSITOL SIGNALING | 18 | 1.17 | 0.0076 |
HSA04020:CALCIUM SIGNALING PATHWAY | 28 | 1.83 | 0.0093 |
HSA00271:METHIONINE METABOLISM | 6 | 0.39 | 0.0099 |
HSA04540:GAP JUNCTION | 16 | 1.04 | 0.0109 |
HSA04530:TIGHT JUNCTION | 18 | 1.17 | 0.0173 |
HSA04910:INSULIN SIGNALING PATHWAY | 21 | 1.37 | 0.0193 |
HSA04630:JAK-STAT SIGNALING PATHWAY | 22 | 1.44 | 0.0326 |
HSA04710:CIRCADIAN RHYTHM | 5 | 0.33 | 0.0370 |
N, number of potential target genes in pathway; %, percent of pathway genes that are targeted by differentiated miRNAs.